GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $71,000 | -60.3% | 152,527 | +25.2% | 0.00% | 0.0% |
| Q4 2015 | $179,000 | +10.5% | 121,805 | +18.9% | 0.00% | 0.0% |
| Q3 2015 | $162,000 | +84.1% | 102,436 | +97.2% | 0.00% | 0.0% |
| Q2 2015 | $88,000 | -38.5% | 51,933 | -49.6% | 0.00% | 0.0% |
| Q1 2015 | $143,000 | -29.6% | 103,034 | +4.7% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -22.8% | 98,452 | +14.7% | 0.00% | -50.0% |
| Q2 2014 | $263,000 | +38.4% | 85,809 | +12.7% | 0.00% | +100.0% |
| Q1 2014 | $190,000 | -49.7% | 76,123 | 0.0% | 0.00% | -66.7% |
| Q4 2013 | $378,000 | +118.5% | 76,123 | 0.0% | 0.00% | +200.0% |
| Q3 2013 | $173,000 | +5.5% | 76,123 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $164,000 | – | 73,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 375,000 | $855,000 | 0.93% |
| HIGHLAND CAPITAL MANAGEMENT LP | 800,000 | $1,824,000 | 0.12% |
| Alyeska Investment Group, L.P. | 780,000 | $1,778,000 | 0.07% |
| KMS FINANCIAL SERVICES, INC | 119,500 | $272,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 539,150 | $1,229,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 25,100 | $57,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 349,400 | $793,000,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 12,000 | $27,000 | 0.02% |
| Diversified Trust Co | 40,000 | $91,000 | 0.01% |
| PITTENGER & ANDERSON INC | 18,000 | $41,000 | 0.01% |